Acute kidney injury in patients using amikacin in an era of carbapenem-resistant bacteria

Felipe Francisco TuonDepartment of Medicine, School of Health and Biosciences, Pontifícia Universidade Católica do Paraná, Curitiba, Brazil; Correspondence[email protected]

Bruna Zanette de AragaoDepartment of Medicine, School of Health and Biosciences, Pontifícia Universidade Católica do Paraná, Curitiba, Brazil;

Thiago Almeida SantosDepartment of Medicine, School of Health and Biosciences, Pontifícia Universidade Católica do Paraná, Curitiba, Brazil;

Juliano GasparettoDepartment of Medicine, School of Health and Biosciences, Pontifícia Universidade Católica do Paraná, Curitiba, Brazil;

Kassia CordovaDepartment of Medicine, Faculdade Evangélica do Paraná, Curitiba, Brazil

Marcela AbujamraDepartment of Medicine, Faculdade Evangélica do Paraná, Curitiba, Brazil

Click to increase image sizeClick to decrease image size

Acknowledgements

We thank the ICU staff for assistance.

Disclosure statement

This study received no support. F.F.T. is a CNPQ member and K.C. is PIBIC student.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Acute kidney injury in patients using amikacin in an era of carbapenem-resistant bacteria

Disclosure statement

Information for

Open access

Opportunities

Help and information

Acute kidney injury in patients using amikacin in an era of carbapenem-resistant bacteria

Acknowledgements

Disclosure statement

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature